Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Blarcamesine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anavex Life Sciences Presents At 35th Alzheimer Europe Conference
    Anavex Life Sciences Presents At 35th Alzheimer Europe Conference

    10 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/10/3164794/29248/en/Anavex-Life-Sciences-Announces-Presentation-at-the-35th-Alzheimer-Europe-Conference-Connecting-Science-and-Communities-The-Future-of-Dementia-Care.html

    GLOBENEWSWIRE
    10 Oct 2025
    Share Share
    Anavex Publishes Blarcamesine Ph IIb/III Alzheimer’s Results
    Anavex Publishes Blarcamesine Ph IIb/III Alzheimer’s Results

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158599/29248/en/Anavex-Life-Sciences-Announces-Publication-of-Oral-Blarcamesine-Describing-a-New-Class-of-Clinical-Precision-Medicine-from-Phase-IIb-III-Alzheimer-s-Disease-Trial.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Anavex Reveals Blarcamesine Results in Ph 2b/3 Alzheimer’s Trial
    Anavex Reveals Blarcamesine Results in Ph 2b/3 Alzheimer’s Trial

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146779/29248/en/Anavex-Life-Sciences-Announces-Oral-Blarcamesine-Cognitive-Resilience-Results-Approximating-Normal-Aging-in-New-Precision-Medicine-Clinical-Data-from-Phase-IIb-III-Alzheimer-s-Dise.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    Anavex Reports Journal on Autophagy Mechanism with Blarcamesine
    Anavex Reports Journal on Autophagy Mechanism with Blarcamesine

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139157/29248/en/Anavex-Life-Sciences-Reports-New-Publication-in-Medical-Journal-Highlighting-the-Established-Precise-Autophagy-Mechanism-with-Blarcamesine.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    Anavex's Blarcamesine Prevents Alzheimer’s in Animal Study
    Anavex's Blarcamesine Prevents Alzheimer’s in Animal Study

    20 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/20/3136316/29248/en/Anavex-Life-Sciences-Announces-New-Publication-in-Medical-Journal-Blarcamesine-Prevented-Cognitive-Impairment-in-Animal-Model-of-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    20 Aug 2025
    Share Share
    Anavex Reports 4-Year Data From Blarcamesine Alzheimer Trial
    Anavex Reports 4-Year Data From Blarcamesine Alzheimer Trial

    31 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3124886/29248/en/Anavex-Life-Sciences-Announces-Positive-Precision-Medicine-Results-from-up-to-4-Years-of-Oral-Blarcamesine-Treatment-in-Phase-IIb-III-Open-Label-Extension-Trial-in-Early-Alzheimer-.html

    GLOBENEWSWIRE
    31 Jul 2025
    Share Share